Evidence mapPaperPMID 40849815Full record

ReviewMolecular medicine reports2025

Potential role of Fanconi anemia pathway in the pathogenesis of endometrial cancer (Review).

Mengmeng Yao, Chuqi Liu, Huiyu Ping, Kaidi Meng, Xinru Li, Qingxin Li, Yuanmin Qi, Ziming Zhu, Li Zhang, Aizhong Han

Abstract readReview
In one paragraph

Review in Molecular medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mengmeng Yao *Lin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.
Chuqi Liu *Lin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.
Huiyu PingLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.
Kaidi MengCollege of Medical Laboratory, Qilu Medical University, Zibo 255300, P.R. China.
Xinru LiLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.
Qingxin LiLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.
Yuanmin QiLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.
Ziming ZhuLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.
Li ZhangDepartment of Gynecology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, P.R. China.
Aizhong HanLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, Shandong 272067, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial cancer (EC) is a common gynecologic malignancy that often exhibits molecular features such as extensive somatic copy number alterations, microsatellite instability and frequent

Indexed as

Endometrial NeoplasmsFanconi AnemiaFanconi Anemia Complementation Group ProteinsDNA DamageDNA RepairFemaleHumansMutationSignal TransductionFanconi Anemia Complementation Group Proteinscell cycleDNA damage repairendometrial cancerFanconi anemiagenomic instability

Identifiers

PMID40849815
PMCPMC12404022

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.